PRFX (PainReform Ltd.) קצב צמיחת רווח למניה בשנה הנוכחית

This daily chart on GURU.Markets for PainReform Ltd. (PRFX) shows the annual EPS variation, where the 0.00 mark indicates the yield level. This price action reflects Israeli developments of slow-release drug formulations. Growth prospects rely on the patent protection of the PRF-110 system, which is awaiting scaling across clinics. The result will be the integration of the drug delivery platform into surgical protocols, creating high switching costs for therapy.

Low production costs for injectable formulas at PainReform Ltd. create powerful operating leverage, amplifying the impact of every sale on the bottom line. The eps_yy_co metric measures the annual growth rate of net income per share, capturing the efficiency of business scaling by calculating the difference between the current and previous periods. The current value of 0.00 in the YoY net income per share trend allows for an assessment of the company's maturity stage and helps avoid purchasing the asset at a historical peak.